Symtuza
Generic name: Cobicistat, Darunavir, Emtricitabine, And Tenofovir
Drug class:
Antiviral combinations
Usage of Symtuza
Symtuza contains a combination of cobicistat, darunavir, emtricitabine, and tenofovir alafenamide. . Cobicistat reduces the action of enzymes in your liver that break down certain antiviral medicines. This allows the antiviral medicines to be used more safely and effectively at lower doses.
Darunavir, emtricitabine and tenofovir are antiviral medicines that prevent human immunodeficiency virus (HIV) from multiplying in your body. HIV can cause acquired immunodeficiency syndrome (AIDS).
Symtuza is an antiviral medicine used to treat human immunodeficiency virus (HIV), the virus that can cause the acquired immunodeficiency syndrome (AIDS). Symtuza is for use in adults and children weighing at least 88 pounds (40 kilograms). This medicine is not a cure for HIV or AIDS.
Symtuza is sometimes used in people who have never been treated with other HIV medications.
Symtuza is also used to replace other HIV medications in adults with suppressed viral loads. Your doctor will determine which medication is best for you.
Symtuza side effects
Get emergency medical help if you have signs of an allergic reaction to Symtuza (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).
Call your doctor at once if you have:
Symtuza can affect your immune system (even weeks or months after you've used Symtuza). Tell your doctor if you have:
Common Symtuza side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Symtuza
Some drugs should not be used with Symtuza. Your treatment plan may change if you also use:
To make sure Symtuza is safe for you, tell your doctor if you have ever had:
You may develop lactic acidosis, a dangerous build-up of lactic acid in your blood. Ask your doctor about your risk.
Symtuza may not work as well if you take it during pregnancy. Do not start taking Symtuza if you are pregnant, and tell your doctor if you become pregnant.
If you plan to get pregnant, ask your doctor for another antiviral medicine to use during pregnancy. To prevent HIV in a newborn baby, use all medications to control your infection during pregnancy. Your name may be listed on an antiviral pregnancy registry.
If you do not plan to get pregnant, ask your doctor about using a non-hormonal birth control (condom, diaphragm, cervical cap, or contraceptive sponge) to prevent pregnancy. Symtuza can increase certain side effects when taken with hormonal birth control (pills, injections, implants, skin patches, vaginal rings).
Women with HIV should not breastfeed. The virus can pass to your baby in your breast milk.
Relate drugs
- AccessPak for HIV PEP Basic
- AccessPak for HIV PEP Expanded with Kaletra
- AccessPak for HIV PEP Expanded with Viracept
- Atazanavir and cobicistat
- Atripla
- Cobicistat and darunavir
- Cobicistat, darunavir, emtricitabine, and tenofovir
- Cobicistat, elvitegravir, emtricitabine, and tenofovir
- Combivir
- Complera
- Abacavir and lamivudine
- Abacavir, dolutegravir, and lamivudine
- Abacavir, lamivudine, and zidovudine
- Bictegravir, emtricitabine, and tenofovir
- Bictegravir, emtricitabine, and tenofovir alafenamide
- Biktarvy
- Cabenuva
- Cabotegravir and rilpivirine
- Casirivimab and imdevimab
- Cilgavimab and tixagevimab
- Cimduo
- Darunavir and cobicistat
- Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide
- Dasabuvir, ombitasvir, paritaprevir, and ritonavir
- Delstrigo
- Descovy
- Descovy Blister Pack
- Dolutegravir and lamivudine
- Dolutegravir and rilpivirine
- Doravirine, lamivudine, and tenofovir
- Dovato
- Efavirenz, emtricitabine, and tenofovir
- Efavirenz, lamivudine, and tenofovir
- Elbasvir and grazoprevir
- Elvitegravir, cobicistat, emtricitabine, and tenofovir
- Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
- Emtricitabine and tenofovir
- Emtricitabine and tenofovir alafenamide
- Emtricitabine, lopinavir, ritonavir, and tenofovir
- Emtricitabine, nelfinavir, and tenofovir
- Emtricitabine, rilpivirine, and tenofovir
- Emtricitabine, rilpivirine, and tenofovir alafenamide
- Epclusa
- Epzicom
- Evotaz
- Evusheld
- Genvoya
- Glecaprevir and pibrentasvir
- Harvoni
- Juluca
- Lamivudine and tenofovir
- Lamivudine and zidovudine
- Ledipasvir and sofosbuvir
- Mavyret
- Nirmatrelvir and ritonavir
- Odefsey
- Ombitasvir, paritaprevir, and ritonavir
- Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Paxlovid
- Prezcobix
- Regen-Cov
- Sofosbuvir and Velpatasvir
- Sofosbuvir, velpatasvir, and voxilaprevir
- Stribild
- Symfi
- Symfi Lo
- Symtuza
- Technivie
- Temixys
- Triumeq
- Triumeq PD
- Trizivir
- Truvada
- Viekira
- Viekira Pak
- Viekira XR
- Vosevi
- Zepatier
How to use Symtuza
Usual Adult Dose of Symtuza for HIV Infection:
1 tablet orally once a day Comments: -This drug is not recommended during pregnancy due to considerably lower exposures of darunavir and cobicistat during the second and third trimesters. -This drug should not be started in pregnant women; patients who become pregnant during therapy with this drug should be switched to an alternative regimen. Use: As a complete regimen for the treatment of HIV-1 infection in patients with no prior antiretroviral treatment history or in patients virologically-suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen for at least 6 months who have no known substitutions associated with resistance to darunavir or tenofovir
Usual Pediatric Dose of Symtuza for HIV Infection:
At least 40 kg: 1 tablet orally once a day Comments: -This drug is not recommended during pregnancy due to considerably lower exposures of darunavir and cobicistat during the second and third trimesters. -This drug should not be started in pregnant women; patients who become pregnant during therapy with this drug should be switched to an alternative regimen. Use: As a complete regimen for the treatment of HIV-1 infection in patients with no prior antiretroviral treatment history or in patients virologically-suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen for at least 6 months who have no known substitutions associated with resistance to darunavir or tenofovir
Warnings
Tell your doctor about all your other medicines. Some drugs should not be used with Symtuza.
Symtuza can cause serious liver problems. Call your doctor if you have upper stomach pain, loss of appetite, vomiting, dark urine, or yellowing of the skin or eyes.
Stop taking Symtuza and call your doctor right away if you have a severe skin reaction: fever, burning or redness in your eyes, mouth sores, or a skin rash that spreads and causes blistering and peeling.
If you've ever had hepatitis B, it may become active or get worse after you stop using Symtuza. You may need frequent liver function tests for several months.
What other drugs will affect Symtuza
Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.
Many drugs can interact with cobicistat, darunavir, emtricitabine, and tenofovir, and some drugs should not be used at the same time. Tell your doctor about all other medicines you use. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions